Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| conventional dendritic cell | 27 studies | 56% ± 18% | |
| classical monocyte | 22 studies | 37% ± 13% | |
| dendritic cell | 18 studies | 47% ± 17% | |
| monocyte | 15 studies | 32% ± 12% | |
| epithelial cell of proximal tubule | 7 studies | 56% ± 16% | |
| enterocyte | 7 studies | 62% ± 25% | |
| non-classical monocyte | 6 studies | 24% ± 11% | |
| mononuclear phagocyte | 5 studies | 47% ± 20% | |
| epithelial cell | 5 studies | 62% ± 13% | |
| goblet cell | 5 studies | 34% ± 12% | |
| intestinal crypt stem cell | 5 studies | 40% ± 21% | |
| macrophage | 5 studies | 43% ± 21% | |
| monocyte-derived dendritic cell | 4 studies | 52% ± 26% | |
| mesothelial cell | 4 studies | 32% ± 13% | |
| progenitor cell | 4 studies | 69% ± 4% | |
| transit amplifying cell | 4 studies | 40% ± 17% | |
| enteroendocrine cell | 3 studies | 36% ± 17% | |
| myeloid cell | 3 studies | 36% ± 24% | |
| intermediate monocyte | 3 studies | 44% ± 7% | |
| acinar cell | 3 studies | 49% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 2214.78 | 89 / 89 | 86% | 161.73 | 776 / 901 |
| pancreas | 100% | 1864.14 | 328 / 328 | 83% | 65.77 | 148 / 178 |
| stomach | 82% | 68.38 | 296 / 359 | 75% | 70.47 | 215 / 286 |
| intestine | 78% | 594.95 | 752 / 966 | 68% | 45.15 | 358 / 527 |
| lung | 86% | 60.06 | 498 / 578 | 48% | 15.72 | 549 / 1155 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 133.01 | 29 / 29 |
| spleen | 100% | 267.44 | 241 / 241 | 0% | 0 | 0 / 0 |
| liver | 54% | 23.42 | 123 / 226 | 35% | 13.54 | 144 / 406 |
| breast | 53% | 19.32 | 244 / 459 | 35% | 7.20 | 393 / 1118 |
| uterus | 54% | 22.27 | 91 / 170 | 32% | 10.78 | 148 / 459 |
| skin | 54% | 22.14 | 972 / 1809 | 31% | 7.33 | 145 / 472 |
| esophagus | 33% | 11.81 | 481 / 1445 | 51% | 35.53 | 93 / 183 |
| adipose | 70% | 86.78 | 847 / 1204 | 0% | 0 | 0 / 0 |
| bladder | 38% | 11.62 | 8 / 21 | 31% | 11.10 | 154 / 504 |
| peripheral blood | 68% | 170.72 | 634 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 67% | 22.03 | 30 / 45 |
| blood vessel | 63% | 20.97 | 838 / 1335 | 0% | 0 | 0 / 0 |
| prostate | 41% | 15.23 | 101 / 245 | 20% | 3.17 | 99 / 502 |
| thymus | 31% | 12.16 | 204 / 653 | 28% | 9.51 | 171 / 605 |
| adrenal gland | 34% | 7.52 | 87 / 258 | 3% | 3.01 | 7 / 230 |
| ovary | 12% | 3.26 | 21 / 180 | 17% | 2.20 | 71 / 430 |
| heart | 13% | 3.69 | 112 / 861 | 0% | 0 | 0 / 0 |
| brain | 6% | 1.75 | 154 / 2642 | 2% | 0.38 | 12 / 705 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.53 | 3 / 80 |
| muscle | 2% | 0.47 | 16 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0043029 | Biological process | T cell homeostasis |
| GO_0050729 | Biological process | positive regulation of inflammatory response |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_1990724 | Cellular component | galectin complex |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0016936 | Molecular function | galactoside binding |
| Gene name | LGALS2 |
| Protein name | Galectin-2 (Gal-2) (Beta-galactoside-binding lectin L-14-II) (HL14) (Lactose-binding lectin 2) (S-Lac lectin 2) Galectin Galectin 2 |
| Synonyms | |
| Description | FUNCTION: This protein binds beta-galactoside. Its physiological function is not yet known. |
| Accessions | P05162 ENST00000416480.1 ENST00000215886.6 Q6PIT8 B0QYC9 |